España
Dado el perfil de mis queridos conforeros, creo que mi lectura veraniega se presta a ser aconsejada:
http://es.scribd.com/doc/3997101/Andre-Kostolany-El-Fabuloso-Mundo-Del-Dinero-Y-La-Bolsa
Saludos.
P.D. gracias por el aviso de STEM.
Un post usano interesante acerca de AMRN y posibles comportamientos en funcion de lo que consigan y sin mantienen o no la puerta abierta a un buy out:
".... The odds of getting the patent...EXTREMELY HIGH, the odds of getting 5 year NCE...EXTREMELY HIGH. The only pullback from AMRN related news would be if they announce no BO and going it on their own. Otherwise the odds of a pullback on bad news seems low(thoguh entirely possible of course) so based on looking to get in on a pullback if everything goes well you'll see 15+ with patent news, 18+ with NCE news and then around 20 if they annnounce they are seeking a BO though its unclear if they would announce their direction or just announce a deal if they were going that route. Buying under 15 at any point can be a good play. Maybe the market will correct and give you and in before the news starts being announced but with so much on the plate for news hard to believe any pullback will be severe..."
Alguien me lo puede explicar ,es que no acabo de entenderlo,Es una farmacéutica CTIC,que creo que hace un split,pero no lo acabo de entender.
Gracias
Por lo menos ir a cerrar el gap en 5,5x...
Mas bien suena a un split inverso, no?
http://finanbolsa.com/2009/07/21/split-y-reverse-split-que-son/
No se si se ha puesto ya,S2
http://www.fiercebiotech.com/story/achillion-pharma-strikes-deal-raise-418m-hep-c-results-loom/2012-08-31
No crees que ya tiene mucho descontado el valor?
Los dos últimos días el volumen ha sido potente.
El problema de estas empresas tan "pequeñas"es la facil manipulacion q tienen...